Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1

Conditions

Neoplasms 5Pain 2Cancer Pain 2Bronchiolitis Obliterans Syndrome 2Osteoarthritis 1Lymphoma, Follicular 1Constipation 1Back Pain 1

Interventions

Fentanyl 19Analgesia 15Acupuncture Therapy 13Oxycodone 12Zoledronic Acid 11Surveys and Questionnaires 10nabiximols 9Therapeutics 9Morphine 9Acetaminophen 9Psychiatric Rehabilitation 8Ketamine 8Hydromorphone 7Lidocaine 6Ibandronic Acid 6Radiotherapy 5Early Intervention, Educational 5Bupivacaine 5Analgesics, Opioid 5Yoga 4Transcutaneous Electric Nerve Stimulation 4Therapeutic Touch 4Ropivacaine 4Music Therapy 4Methadone 4Massage 4Aromatherapy 4alvimopan 3Tapentadol 3Saline Solution 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Pain × Naloxone × Clear all
NCT01885182 2019-10-04

Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Completed
232 enrolled 16 charts

Neoplasms, Pain

NCT00513656 2018-10-23

A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain

Mundipharma Research GmbH & Co KG

Phase 2 Completed
230 enrolled
Other

Bronchiolitis Obliterans Syndrome, Constipation, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡